Clinical Trial Update: Dose-Escalation Study of HTX-034 Following Bunionectomy [Phase 1, Phase 2]

View source ↗

Summary

A dose-escalation study of HTX-034 following bunionectomy has completed Phase 1/Phase 2 trials.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bunion
• Bunions

Drugs mentioned

• HTX-034

Snippet

Sponsor: Heron Therapeutics | Conditions: Bunions | Phase 1, Phase 2 | Status: COMPLETED